Q-Sera



Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

Transforming the Blood Collection Tube market
Serum is the gold standard for biochemical analysis. Serum is produced when a blood sample clots and the clotted cells are removed by centrifugation. Preparation of high quality Pre-analytical samples is important to ensure accurate analytical results and patient outcomes. Current tubes use an inefficient clot activator and are unable to clot the blood of some patients – such as anticoagulated cardiac patients or those taking common medicines such as warfarin or other oral anticoagulants. The rapid production of high quality serum is important to improve laboratory efficiency and is vital to optimize patient outcomes.

For many years, the industry has recognized the need for a tube that rapidly produced high quality serum from the majority of blood samples. Q-Sera’s technology has been developed to create a new standard biochemistry tube to meet these needs and uses pro-coagulant proteins called prothrombin activators, the use of which is covered by global patent protection. These proteins are found in the venom of some snakes (including the Australian Taipan) that have a potent ability to coagulate the blood and are now manufactured ‘recombinantly’ using industry standard protein production technologies.

Category: Health & biotech
URL: https://www.q-sera.com/
Operational Status: Active
ASX Listing Code (if applicable):
Year of Commencement:
Address:

Victoria, 3000

State: Victoria
Overseas Operations: No
X:
Facebook:
Linkedin:
Founders:
No items found
Awards won: